Immunotherapy for cervical cancer

Immunotherapy helps to strengthen or restore the immune system's ability to fight cancer. This works to kill cancer cells and stop cancer cells from growing and spreading.

Immunotherapy is sometimes used to treat cervical cancer that comes back (recurs) after it has been treated. If you have immunotherapy, your healthcare team will use what they know about the cancer and about your health to plan the drugs, doses and schedules.

The immune system normally stops itself from attacking healthy cells in the body by using specific proteins called checkpoints. Checkpoints slow down or stop an immune system response. Some cervical cancer cells can use these checkpoints to hide and avoid being attacked by the immune system. Immune checkpoint inhibitors work by blocking the checkpoint proteins so immune system cells (called T-cells) attack and kill the cancer cells.

The immune checkpoint inhibitor drugs used for cervical cancer are cemiplimab (Libtayo) and pembrolizumab (Keytruda). These drugs target the PD-L1 checkpoint.

Cemiplimab is offered for recurrent cervical cancer if:

  • chemotherapy was already used to treat metastatic cervical cancer, but it didn't respond
  • the cancer has come back after being treated with chemotherapy

Pembrolizumab may also be offered for recurrent or metastatic cervical cancer in combination with chemotherapy. You may also receive the targeted therapy drug bevacizumab (Avastin).

Side effects of immunotherapy

Side effects of immunotherapy will depend mainly on the type of drug or drug combination, the dose, how it's given and your overall health. Tell your healthcare team if you have side effects that you think might be from immunotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

These are common side effects of immunotherapy for cervical cancer:

Find out more about immunotherapy

To make the decisions that are right for you, ask your healthcare team questions about immunotherapy.

Details on specific drugs change regularly. Find out more about sources of drug information and where to get details on specific drugs.

Révision par les experts et références

  • American Cancer Society. Treating Cervical Cancer. 2021. https://www.cancer.org/.
  • Chuang LT, Temin S, Berek JS. Management and care of patients with invasive cervical cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update. JCP Global Oncology. 8:1-4.
  • Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023. International Journal of Gynecological Cancer. 2023: 33:649-666.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer Version 1.2023. 2023.
  • PDQ Adult Treatment Editorial Board. Cervical Cancer Treatment] (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2023. https://www.cancer.gov/.

Votre source de confiance pour des informations fiables sur le cancer

Le soutien des lecteurs comme vous nous permet de continuer à fournir des informations de la plus haute qualité sur plus de 100 types de cancer.

Nous sommes là pour vous garantir un accès facile à des informations fiables sur le cancer, ainsi qu’aux millions de personnes qui visitent ce site Web chaque année. Mais nous ne pouvons pas y arriver seuls.

Chaque don nous permet d’offrir des informations fiables sur le cancer et finance des services de soutien empreints de compassion et des projets de recherche prometteurs. Faites un don dès maintenant, car chaque dollar compte. Nous vous remercions.

Non-responsabilité médicale

L'information fournie par la Société canadienne du cancer ne saurait remplacer le lien qui vous unit à votre médecin. Nos renseignements sont d’ordre général; avant de prendre toute décision de nature médicale ou si vous avez des questions concernant votre état de santé personnel, assurez-vous de parler à un professionnel de la santé qualifié.

Nous faisons le maximum pour que les renseignements que nous diffusons soient toujours exacts et fiables, mais nous ne pouvons garantir leur exhaustivité, pas plus que l’absence totale d’erreur.

La Société canadienne du cancer n’assume aucune responsabilité quant à la qualité des renseignements ou des services offerts par d'autres organismes mentionnés sur cancer.ca, pas plus qu’elle ne cautionne un service, un produit, un traitement ou une thérapie en particulier. 


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society